Search...
Features
Assets
Blog
Help
Learn
Get App
Login
Sign Up
Get App
Arrowhead Pharmaceuticals (ARWR) Q3 2024 Earnings
ARWR
-4.84%
8
Aug
Confirmed
Q4 2023
Q1 2024
Q2 2024
Q3 2024
-1.92
-1.44
-0.95
-0.47
Details
Expected EPS
-0.528927
Actual EPS
-1.38
Surprise EPS
-0.85
Surprise Percent
+160.91%
Description
Arrowhead Pharmaceuticals (ARWR) has reported earnings of -1.38 per share for Q3 2024.
0 Comments
Share your thoughts
Get the Stock Events App
Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.
Sign Up
Login